Wolverine Trading
AGIO icon

Wolverine Trading’s Agios Pharmaceuticals AGIO Stock Holding History

Wolverine Trading’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-4,945
Closed -$245K – 5785
2020
Q4 		$220K Buy
+4,945
New +$196K ﹤0.01% 4106
2020
Q2 		– Sell
-7,513
Closed -$348K – 4497
2020
Q1 		$266K Buy
+7,513
New +$347K ﹤0.01% 3353
2019
Q3 		– Sell
-6,837
Closed -$283K – 4214
2019
Q2 		$341K Buy
+6,837
New +$365K ﹤0.01% 3132
2017
Q3 		– Sell
-5,385
Closed -$282K – 4348
2017
Q2 		$282K Buy
+5,385
New +$275K ﹤0.01% 3135

Other funds holding AGIO

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Wolverine Trading's AGIO Position: Q1 2021 in Review

Wolverine Trading sold out of Agios Pharmaceuticals (AGIO) in Q1 2021, closing a stake of 4,945 shares — an estimated $245K sold.

Wolverine Trading first reported a position in AGIO in Q2 2017 and held it in 4 quarters. The position peaked at $341K in Q2 2019. 174 funds tracked by Wall St. Rank hold AGIO as of Q1 2021.

  • Wolverine Trading reported no remaining Agios Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Wolverine Trading sold 4,945 Agios Pharmaceuticals shares in Q1 2021, an estimated $245K.
  • Wolverine Trading first reported a position in Agios Pharmaceuticals in Q2 2017 and held it in 4 quarters.
  • Wolverine Trading's Agios Pharmaceuticals position peaked at $341K in Q2 2019.
  • 174 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2021.

Based on Wolverine Trading's 13F filing for Q1 2021, filed 14 May 2021.